Blog

Sean Gill

Recent Posts

Four Ways to Close the Execution Gap in Global Healthcare Programs
September 15, 2026 Sean Gill

Global healthcare programs are often judged by one simple measure: did they work in every market?

Read more
Determining the Appropriate Level of Local Adaptation in a Global Program
September 8, 2026 Sean Gill

This excerpt is from our recent whitepaper, How Pharma Can Use Behavioral Science to Balance Global Strategy with Local Relevance,...

Read more
What
June 24, 2026 Sean Gill

In 2019, Babylon Health was among the most-funded digital health companies in the world. Their AI symptom checker told millions of...

Read more
The Value of Behavior Mapping for Pharma (Part 2) | Processes & Best Practices
September 9, 2025 Sean Gill

This post is the second in a two-part series exploring the role of behavior mapping in the pharma industry, click the following link...

Read more
The Value of Behavior Mapping for Pharma (Part 1) | Challenges & Benefits
August 26, 2025 Sean Gill

This post is the first in a two-part series exploring the role of behavior mapping in the pharma industry. Across the series, we...

Read more
The Affinial Digital Health Platform – The Role of Dynamic Nudges in Therapy Adherence
September 19, 2023 Sean Gill

In our previous article, we discussed the importance of patient engagement, and involving patients in their health and well-being...

Read more
The Affinial Digital Health Platform – Empowering Personalized Patient Engagement in Digital Health Solutions
September 5, 2023 Sean Gill

Patient engagement is the process of involving patients in their health and well-being journey, taking into account their thoughts,...

Read more
Rethinking adherence programs
January 29, 2019 Sean Gill

Article published by Sean Gill, Principal Behavioral Scientist, S3 Connected Health on PharmaPhorum on 22 January 2019.

Read more
Tags